Ensuring Day 1 Readiness for Innovative Oncology Therapy

An emerging pharmaceutical manufacturer found itself with a rapidly-approaching launch window after receiving accelerated regulatory approval. However, they didn’t have the policies, standard operating procedures, contracts and operational capabilities to be ready for Day 1.

Like many pre-commercial companies, they turned to IntegriChain to help them prepare for launch. This case study highlights IntegriChain’s unique combination of launch expertise, managed services excellence and customer-centered approach that explains why more than 100 companies have selected IntegriChain as their launch partner in just the past three years. 

Download now!

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand